The global market for Glucose Monitoring Devices was estimated at US$14.6 Billion in 2024 and is projected to reach US$19.2 Billion by 2030, growing at a CAGR of 4.6% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Glucose Monitoring Devices market.
Continued market expansion hinges on technological progress, healthcare integration, and the escalating diabetes burden worldwide. Innovations like non-invasive technologies, AI integration, and wearable devices are shaping the future landscape, promising enhanced diabetes management and patient care. As these solutions become more accessible, they`re expected to significantly improve global diabetes management, especially as healthcare infrastructure strengthens in emerging economies, presenting ample growth opportunities for manufacturers.
Key market drivers and trends include technological leaps such as CGM systems, which provide real-time insights into glucose levels, and the integration of AI into glucose monitoring, AI is increasingly being incorporated into glucose monitoring systems to enhance the predictive accuracy of devices. These systems can analyze data over time to predict future trends in glucose levels, enabling preemptive management of potential issues. Artificial Intelligence (AI) is reshaping many aspects of healthcare, including diabetes management Government policies promoting better screening and monitoring, alongside patient education emphasizing self-monitoring, further drive adoption. Wearable glucose monitors that seamlessly integrate with everyday life are gaining traction. These devices continuously track glucose levels and offer the convenience of not having to perform multiple daily finger-prick tests.
Global Glucose Monitoring Devices Market - Key Trends and Drivers Summarized
The market for glucose monitoring devices is experiencing rapid growth, fueled by technological advancements, increasing diabetes prevalence, and a rising emphasis on proactive health management. Global diabetes rates are climbing due to factors such as obesity, aging populations, and lifestyle habits such as poor diet and inactivity, amplifying the need for effective monitoring solutions. Continuous Glucose Monitors (CGMs) have evolved significantly, offering high accuracy and simplicity beyond their original insulin therapy support.Continued market expansion hinges on technological progress, healthcare integration, and the escalating diabetes burden worldwide. Innovations like non-invasive technologies, AI integration, and wearable devices are shaping the future landscape, promising enhanced diabetes management and patient care. As these solutions become more accessible, they`re expected to significantly improve global diabetes management, especially as healthcare infrastructure strengthens in emerging economies, presenting ample growth opportunities for manufacturers.
Key market drivers and trends include technological leaps such as CGM systems, which provide real-time insights into glucose levels, and the integration of AI into glucose monitoring, AI is increasingly being incorporated into glucose monitoring systems to enhance the predictive accuracy of devices. These systems can analyze data over time to predict future trends in glucose levels, enabling preemptive management of potential issues. Artificial Intelligence (AI) is reshaping many aspects of healthcare, including diabetes management Government policies promoting better screening and monitoring, alongside patient education emphasizing self-monitoring, further drive adoption. Wearable glucose monitors that seamlessly integrate with everyday life are gaining traction. These devices continuously track glucose levels and offer the convenience of not having to perform multiple daily finger-prick tests.
SCOPE OF STUDY:
The report analyzes the Glucose Monitoring Devices market in terms of units by the following Segments, and Geographic Regions/Countries:- Segments: Product Type (Self-Monitoring Devices, Continuous Blood Glucose Monitoring Devices); End-Use (Hospitals, Home Care, Diagnostic Centers)
- Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Self-Monitoring Devices segment, which is expected to reach US$11.3 Billion by 2030 with a CAGR of a 3.7%. The Continuous Blood Glucose Monitoring Devices segment is also set to grow at 6.0% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, valued at $3.9 Billion in 2024, and China, forecasted to grow at an impressive 7.6% CAGR to reach $4.1 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Glucose Monitoring Devices Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Glucose Monitoring Devices Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Glucose Monitoring Devices Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of players such as Abbott Diabetes Care, Inc., ACON Laboratories, Inc., AgaMatrix, Inc., Alive Technologies Pty. Ltd., ARKRAY, Inc. and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Some of the 32 companies featured in this Glucose Monitoring Devices market report include:
- Abbott Diabetes Care, Inc.
- ACON Laboratories, Inc.
- AgaMatrix, Inc.
- Alive Technologies Pty. Ltd.
- ARKRAY, Inc.
- Ascensia Diabetes Care Holdings AG
- B. Braun Melsungen AG
- Beurer GmbH
- Dexcom, Inc.
- GlySens Inc.
- LifeScan, Inc.
- Medtronic plc
- Nova Biomedical Corporation
- Omron Healthcare Co., Ltd.
- Roche Diagnostics
- Senseonics Holdings, Inc.
- Terumo Corporation
- Trividia Health, Inc.
- Ypsomed Holding AG
This edition integrates the latest global trade and economic shifts as of June 2025 into comprehensive market analysis. Key updates include:
- Tariff and Trade Impact: Insights into global tariff negotiations across 180+ countries, with analysis of supply chain turbulence, sourcing disruptions, and geographic realignment. Special focus on 2025 as a pivotal year for trade tensions, including updated perspectives on the Trump-era tariffs.
- Adjusted Forecasts and Analytics: Revised global and regional market forecasts through 2030, incorporating tariff effects, economic uncertainty, and structural changes in globalization. Includes segmentation by product, technology, type, material, distribution channel, application, and end-use, with historical analysis since 2015.
- Strategic Market Dynamics: Evaluation of revised market prospects, regional outlooks, and key economic indicators such as population and urbanization trends.
- Innovation & Technology Trends: Latest developments in product and process innovation, emerging technologies, and key industry drivers shaping the competitive landscape.
- Competitive Intelligence: Updated global market share estimates for 2025, competitive positioning of major players (Strong/Active/Niche/Trivial), and refined focus on leading global brands and core players.
- Expert Insight & Commentary: Strategic analysis from economists, trade experts, and domain specialists to contextualize market shifts and identify emerging opportunities.
- Complimentary Update: Buyers receive a free July 2025 update with finalized tariff impacts, new trade agreement effects, revised projections, and expanded country-level coverage.
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIV. COMPETITION
1. MARKET OVERVIEW
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Diabetes Care, Inc.
- ACON Laboratories, Inc.
- AgaMatrix, Inc.
- Alive Technologies Pty. Ltd.
- ARKRAY, Inc.
- Ascensia Diabetes Care Holdings AG
- B. Braun Melsungen AG
- Beurer GmbH
- Dexcom, Inc.
- GlySens Inc.
- LifeScan, Inc.
- Medtronic plc
- Nova Biomedical Corporation
- Omron Healthcare Co., Ltd.
- Roche Diagnostics
- Senseonics Holdings, Inc.
- Terumo Corporation
- Trividia Health, Inc.
- Ypsomed Holding AG
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 268 |
| Published | July 2025 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 14.6 Billion |
| Forecasted Market Value ( USD | $ 19.2 Billion |
| Compound Annual Growth Rate | 4.6% |
| Regions Covered | Global |
